Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07740499) titled 'TOLerogenic Potential of Hematopoietic Stem and Progenitor Cells and Inflammatory Bowel Disease' on July 23.
Study Type: Observational
Primary Sponsor: IRCCS San Raffaele
Condition:
Inflammatory Bowel Disease (Crohn's Disease
Ulcerative Colitis)
Intervention:
Procedure: biological sample collection: an additional volume of peripheral blood (3-10 ml)
Procedure: biological sample collection: small fragment (1-5 mm) of intestinal tissue - residual or leftover material
Recruitment Status: Not recruiting
Date of First Enrollment: October 2026
Target Sample Size: 80
Countries of Recruitment:
Italy
To know more, ...